PA
REPL icon

Pineridge Advisors’s Replimune Group REPL Stock Holding History

Pineridge Advisors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$629 Buy
+150
New +$959 ﹤0.01% 412

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pineridge Advisors's REPL Position: Q3 2025 in Review

Pineridge Advisors opened a new position in Replimune Group (REPL) in Q3 2025: 150 shares worth $629. The stake represents ﹤0.01% of the portfolio and ranks #412 among its holdings.

163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

  • Pineridge Advisors held 150 shares of Replimune Group worth $629 as of Q3 2025.
  • Replimune Group was a new Pineridge Advisors position in Q3 2025.
  • Replimune Group made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #412 holding.
  • 163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.